Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists


1545 Park Avenue
Emeryville, CA 94608
Website Company Summary Management Team

CEO: Brian Thomas (9/30/2016)
General Management: Gregory Cost (12/31/2019)
Technology: Alan Brooks (11/30/2019)
Business Development: Christine Foster ; Jak Knowles

Outside board: (May no longer be on the board) Andrew Farquharson (InCube Crowdfunding Managing Director) Jürg Eckhardt (Leaps by Bayer, Bayer Head);  Sebastian Bernales (UCSF Cell Biologist)

Business description: At Metagenomi, we are accelerating innovation in cell and gene therapy with a wave of proprietary CRISPR-based systems to accurately edit DNA where current technologies cannot. Our metagenomics-powered discovery platform and analytical expertise reveal novel cellular machinery sourced from otherwise unknown organisms. We adapt and forge these naturally evolved systems into powerful therapeutic tools that can be leveraged by partners and fuel our own pipeline of potentially curative medicines. Our goal is to revolutionize gene editing and unlock its power for the benefit of patients around the world.

Rounds: 3
Recent Fundings: Jan 2022   Nov 2020
Capital raised: 264.40M
Last Round: 175.0M
Ownership: Private  
VCs include: InCube Ventures Sozo Ventures ;  VentureHealth;  HOF Capital ;  Agent Capital ;  Humboldt Fund Leaps by Bayer
Corporate investors: Bristol Myers Squibb;  Surveyor Capital

Last Tweets


Last Mentions

Record updated: Jan 2022
Sector: Biotech
Year Founded: 2018
Headcount: 101-150 as of May 2022
Rounds: 3
Recent Fundings: Jan 2022   Nov 2020
Capital Raised: 264.40M
Last Round: 175.0M
Ownership: Private